Dr. Michael E. Cannon, MD

Dr. Cannon practices at Gastrointestinal Endoscopy Center - Troy in Troy, Michigan.

Dr. Cannon's NPI, 1184613879, was assigned on October 17, 2005. Dr. Cannon graduated from Wayne State University School Of Medicine in 1992. Dr. Cannon holds Michigan license 059297.

Dr. Cannon's primary practice is Gastrointestinal Endoscopy Center - Troy, at 264 W Maple Road, Suite 100, Troy, MI 48084. The practice phone is (248) 269-5594.

Dr. Cannon's primary practice is Gastrointestinal Endoscopy Center - Troy in Troy, Michigan. The medical group on file is Gastrointestinal Specialists, P.C. Dmand AI also links Dr. Cannon to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cannon practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Cannon's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Cannon is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Cannon is licensed in Michigan.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Cannon treats.

CMS data shows 575 Medicare services from Dr. Cannon across 12 procedure codes in 2024, for 280 Medicare patients. Medicare paid $49,235 for them.

CMS counts 280 Medicare patients who saw Dr. Cannon in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cannon's median patient age at 51, with 48% women.

In 2024, Dr. Cannon wrote 418 Medicare Part D claims for 137 patients. 85% of them were for generic drugs. CMS names the drug for 285 of them, across 11 drugs with 11 or more claims each, at $90,347 in total drug cost. In 2023, CMS named 593 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Cannon for performance year 2024, reported as part of a group.

Dmand AI links 12 papers to Dr. Cannon, published from 2007 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Ampulla of Vater, Arterioles and Cholangiopancreatography, Endoscopic Retrograde. Dr. Cannon has published most often in ACG Case Rep J. Dr. Cannon's most frequent co-authors are Michael E. Cannon, MD, Mitchell Cappell, MD and Seifeldin M.s. Hakim, MD.

CMS Open Payments shows 61 general payments to Dr. Cannon from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $597.

Dmand AI lists 3 awards for Dr. Cannon, most recently Checkbook Top Doc in 2003.

Dr. Cannon graduated from Wayne State University School Of Medicine in 1992. Dr. Cannon is a member of ACG, ACP, AGA and ASGE.

Dr. Cannon is in network with 7 carriers, including Excellus BlueCross BlueShield, Priority Health and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.